Short-Term Outcomes following “Switching” to Monthly Ranibizumab in Neovascular Age-Related Macular Degeneration Showing Insufficient Response to Bimonthly Aflibercept

RESULTS: CRT and logMAR VA were 349.62 ± 223.51 μm and 0.50 ± 0.23 at the baseline and 274.69 ± 148.77 μm and 0.46 ± 0.24, 311.54 ± 192.90 μm and 0.45 ± 0.20 at 1 month after the first and third ranibizumab injections, respectively. The CRT decrease during three ranibizumab injections was statistica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jong Suk, Kang, Hyun Goo, Lee, Christopher Seungkyu, Woo, Se Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376439/
https://www.ncbi.nlm.nih.gov/pubmed/34422404
http://dx.doi.org/10.1155/2021/5547686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376439/
https://www.ncbi.nlm.nih.gov/pubmed/34422404
http://dx.doi.org/10.1155/2021/5547686

Ejemplares similares